NEW YORK (GenomeWeb) – In Nature Genetics, an American- and Finnish-led team described the apparent effects of an EGLN1 mutation that's been linked to high-altitude adaptations in the absence of increased hemoglobin levels in individuals from Tibet.
Registering provides access to this and other free content.
Already have an account?Login Now.
While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.
Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.
In Nature this week: paternal age associated with de novo mutations in children, and more.
Nature News writes that researchers are still wrangling over the role of the p-value.
This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.
This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.